ANNX has 36-month beta value of 1.26. Analysts have mixed views on the stock, with 5 analysts rating it as a “buy,” 3 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for ANNX is 95.53M, and currently, short sellers hold a 10.44% ratio of that float. The average trading volume of ANNX on June 20, 2025 was 1.74M shares.
ANNX) stock’s latest price update
Annexon Inc (NASDAQ: ANNX)’s stock price has gone decline by 0.00 in comparison to its previous close of 2.34, however, the company has experienced a -7.14% decrease in its stock price over the last five trading days. globenewswire.com reported 2025-06-18 that Dr. Clark Brings 25 Years of Experience Treating Retina Diseases and Developing Emerging Therapies as a Principal Investigator in Over 70 Clinical Trials and as an Early Pioneer of VEGF Inhibitors
ANNX’s Market Performance
Annexon Inc (ANNX) has seen a -7.14% fall in stock performance for the week, with a 11.96% gain in the past month and a -6.40% plunge in the past quarter. The volatility ratio for the week is 3.63%, and the volatility levels for the past 30 days are at 5.24% for ANNX. The simple moving average for the past 20 days is 0.80% for ANNX’s stock, with a -43.89% simple moving average for the past 200 days.
Analysts’ Opinion of ANNX
Many brokerage firms have already submitted their reports for ANNX stocks, with JP Morgan repeating the rating for ANNX by listing it as a “Overweight.” The predicted price for ANNX in the upcoming period, according to JP Morgan is $11 based on the research report published on March 01, 2024 of the previous year 2024.
BofA Securities, on the other hand, stated in their research note that they expect to see ANNX reach a price target of $6, previously predicting the price at $4. The rating they have provided for ANNX stocks is “Buy” according to the report published on December 21st, 2023.
Wells Fargo gave a rating of “Overweight” to ANNX, setting the target price at $11 in the report published on October 30th of the previous year.
ANNX Trading at 18.78% from the 50-Day Moving Average
After a stumble in the market that brought ANNX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -70.19% of loss for the given period.
Insider Trading
Reports are indicating that there were more than several insider trading activities at ANNX starting from Dananberg Jamie, who sale 5,521 shares at the price of $2.96 back on Feb 18 ’25. After this action, Dananberg Jamie now owns 33,479 shares of Annexon Inc, valued at $16,342 using the latest closing price.
ARTIS DEAN RICHARD, the EVP & CHIEF SCIENTIFIC OFFICER of Annexon Inc, sale 5,515 shares at $2.97 during a trade that took place back on Feb 18 ’25, which means that ARTIS DEAN RICHARD is holding 83,814 shares at $16,380 based on the most recent closing price.
Stock Fundamentals for ANNX
The total capital return value is set at -0.68. Equity return is now at value -66.13, with -55.14 for asset returns.
Based on Annexon Inc (ANNX), the company’s capital structure generated 0.1 points at debt to capital in total, while cash flow to debt ratio is standing at -4.94.
Currently, EBITDA for the company is -134.75 million with net debt to EBITDA at 0.38. The liquidity ratio also appears to be rather interesting for investors as it stands at 7.99.
Conclusion
To put it simply, Annexon Inc (ANNX) has had a bad performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
